Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 1 of 1 Results
All Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
Effectiveness and Safety of New Dose of Copaxone® Compared to the Currently Approved Dose
- Condition(s):
- Relapse-Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 18 Years to 50 Years
- Interventions:
- Drug: glatiramer acetate 20 mg | Drug: glatiramer acetate 40 mg